GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inspire Medical Systems Inc (STU:2DR) » Definitions » ROE %

Inspire Medical Systems (STU:2DR) ROE % : 10.93% (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Inspire Medical Systems ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Inspire Medical Systems's annualized net income for the quarter that ended in Sep. 2024 was €66.7 Mil. Inspire Medical Systems's average Total Stockholders Equity over the quarter that ended in Sep. 2024 was €610.2 Mil. Therefore, Inspire Medical Systems's annualized ROE % for the quarter that ended in Sep. 2024 was 10.93%.

The historical rank and industry rank for Inspire Medical Systems's ROE % or its related term are showing as below:

STU:2DR' s ROE % Range Over the Past 10 Years
Min: -30.96   Med: -20.11   Max: 5.43
Current: 5.43

During the past 9 years, Inspire Medical Systems's highest ROE % was 5.43%. The lowest was -30.96%. And the median was -20.11%.

STU:2DR's ROE % is ranked better than
62.34% of 802 companies
in the Medical Devices & Instruments industry
Industry Median: -0.145 vs STU:2DR: 5.43

Inspire Medical Systems ROE % Historical Data

The historical data trend for Inspire Medical Systems's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inspire Medical Systems ROE % Chart

Inspire Medical Systems Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only -22.16 -29.88 -19.00 -12.63 -3.91

Inspire Medical Systems Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.41 10.47 -6.90 6.41 10.93

Competitive Comparison of Inspire Medical Systems's ROE %

For the Medical Devices subindustry, Inspire Medical Systems's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inspire Medical Systems's ROE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inspire Medical Systems's ROE % distribution charts can be found below:

* The bar in red indicates where Inspire Medical Systems's ROE % falls into.



Inspire Medical Systems ROE % Calculation

Inspire Medical Systems's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-19.397/( (468.232+524.995)/ 2 )
=-19.397/496.6135
=-3.91 %

Inspire Medical Systems's annualized ROE % for the quarter that ended in Sep. 2024 is calculated as

ROE %=Net Income (Q: Sep. 2024 )/( (Total Stockholders Equity (Q: Jun. 2024 )+Total Stockholders Equity (Q: Sep. 2024 ))/ count )
=66.664/( (592.768+627.602)/ 2 )
=66.664/610.185
=10.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2024) net income data. ROE % is displayed in the 30-year financial page.


Inspire Medical Systems  (STU:2DR) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2024 )
=Net Income/Total Stockholders Equity
=66.664/610.185
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(66.664 / 732.3)*(732.3 / 697.022)*(697.022 / 610.185)
=Net Margin %*Asset Turnover*Equity Multiplier
=9.1 %*1.0506*1.1423
=ROA %*Equity Multiplier
=9.56 %*1.1423
=10.93 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2024 )
=Net Income/Total Stockholders Equity
=66.664/610.185
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (66.664 / 73.256) * (73.256 / 51.604) * (51.604 / 732.3) * (732.3 / 697.022) * (697.022 / 610.185)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.91 * 1.4196 * 7.05 % * 1.0506 * 1.1423
=10.93 %

Note: The net income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Inspire Medical Systems ROE % Related Terms

Thank you for viewing the detailed overview of Inspire Medical Systems's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Inspire Medical Systems Business Description

Traded in Other Exchanges
Address
5500 Wayzata Boulevard, Suite 1600, Golden Valley, MN, USA, 55416
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Inspire Medical Systems Headlines

No Headlines